MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Depression in Parkinson’s disease is associated with subcortical neurodegeneration and increased risk of all-cause mortality and dementia

    J. Badenoch, A. Paris, B. Jacobs, A. Noyce, C. Marshall, S. Waters (London, United Kingdom)

    Objective: To evaluate the temporality, neuroanatomical correlates and prognostic significance of depression in PD using a large population cohort. Background: Depression may be an important…
  • 2023 International Congress

    Reliability of the severity subscale of the Toronto Western Spasmodic Torticollis Rating Scale in a multidisciplinary team

    S. Kassaye, W. de Hertogh, S. de Waele, D. Crosiers, E. Gudina, J. de Pauw (Molenstraat 56, Belgium, Ethiopia)

    Objective: To assess the inter-rater reliability of the severity subscale of the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) in a multidisciplinary team. Background: The…
  • 2023 International Congress

    Gray matter volume changes in occipital and temporal visual brain region are associated with freezing of gait in Parkinson’s

    YX. Li, ZL. Luo, XL. Yang (Kunming, China)

    Objective: This study aimed to investigate the association of changed gray matter volume(GMV)with Freezing of gait(FOG) in Parkinson’s disease(PD). Background: FOG is a characteristic gait…
  • 2023 International Congress

    Prevalence of depression and cognitive impairment in a Hungarian Parkinson’s disease Center

    EK. Balogh, E. Balogh, A. Mező, M. Bokor (Budapest, Hungary)

    Objective: Our aim is to determine the prevalence of depression and cognitive impairment (CI) among our PD patients. Background: Depression and CI are the most…
  • 2023 International Congress

    Identification of ZYIL1, a novel NLR family pyrin domain containing 3 protein inhibitor: a potential disease modifier in Parkinson’s disorder

    A. Chatterjee (Ahmedabad, India)

    Objective: Identification and evaluation of the potential of a novel NLR family pyrin domain containing 3 (NLRP3) inflammasome inhibitor (ZYIL1) as a Parkinson’s disease (PD)…
  • 2023 International Congress

    Topography of cholinergic vulnerability correlates of PIGD motor deficits in DLB and PSP: A [18F]-FEOBV PET study

    P. Kanel, T. Brown, S. Roytman, J. Barr, C C. Spears, N. Bohnen (Ann Arbor, USA)

    Objective: To understand the relationship between cholinergic vulnerability and Postural Instability and Gait Disturbances (PIGD) motor features in dementia with Lewy bodies (DLB), and progressive…
  • 2023 International Congress

    Outcomes of Focused Ultrasound Thalamotomy in Tremor Syndromes

    J. Peters, J. Maamary, K. Kyle, N. Olsen, L. Jones, S. Bolitho, Y. Barnett, B. Jonker, S. Tisch (Darlinghurst, Australia)

    Objective: To report on the outcomes between tremor subtypes, Essential Tremor (ET), Dystonic Tremor (DT) and Parkinson Disease Tremor (PDT), following a unilateral Magnetic Resonance…
  • 2023 International Congress

    Testing the applicability of the dysarthria analyzer to detect levodopa effects on speech in a German cohort of people with Parkinson’s disease

    T. Thies, J. Schreen, H. Jergas, M. Barbe (Cologne, Germany)

    Objective: To test the applicability of “the dysarthria analyzer” in a levodopa challenge test to determine short term effects of levodopa on acoustic speech parameters.…
  • 2023 International Congress

    Cholinergic topography and clinical profile of early Parkinson’s patients with GBA mutations

    S. Slingerland, S. Vander Zee, G. Carli, A. Slomp, J. Boertien, T. van Laar (Groningen, Netherlands)

    Objective: To explore the regional cholinergic innervation and clinical profile of early Parkinson’s disease (PD) patients carrying GBA mutations (GBA-PD). Background: The most common genetic…
  • 2023 International Congress

    Can a global measure of cognition be used to inform balance interventions in Parkinson’s disease?

    N. Burt, K. Arabian, S. Parrott, R. Gallagher (Old Westbury, USA)

    Objective: To examine the relationship between domains of cognition, using the Montreal Cognitive Assessment (MoCA), and domains of balance, using the Mini Balance Evaluation Systems…
  • « Previous Page
  • 1
  • …
  • 253
  • 254
  • 255
  • 256
  • 257
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley